Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation in vitro

Brain Research

Volumn 1107, Issue 1, 2006, Pages 192-198

  Wagner, Caroline ^a   Fachinetto, Roselei ^a   Dalla Corte, Cristiane Lenz ^a   Brito, Verônica Bidinotto ^a   Severo, Diego ^a   de Oliveira Costa Dias, Gilvan ^b   Morel, Ademir F ^b   Nogueira, Cristina W ^a   Rocha, João B T ^a  

^a Laboratorio de Sintese   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Deoxyribose degradation; Fenton reaction; Flavonoids; Oxidative stress; Quercitrin; Quinolinic acid; Sodium nitroprusside; TBARS

Indexed keywords

EDETIC ACID; GLYCOSIDE; IRON; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROPRUSSIDE SODIUM; POTASSIUM FERRICYANIDE; QUERCITRIN; QUINOLINIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; ENZYME DEGRADATION; FENTON REACTION; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84984550472     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.084     Document Type: Article

References (74)

1. Alexi T., Borlongan C., Faull C., Williams C., Clark R., Gluckman P., and Hughes P. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Progr. Neurobiol. 60 (2000) 409-470
2. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Achd. Sci. U. S. A. 90 (1993) 7915-7922
3. Arnold W.P., Longnecker D.E., and Epstein R.M. Photodegradation of sodium nitroprusside: biologic activity and cyanide release. Anesthesiology 61 (1984) 254-260
4. Aruoma O.I., Bahorun T., and Jen L. Neuroprotection by bioactive components in medicinal and food plant extracts. Mut. Res. 544 (2003) 203-215
5. Azbill R.D., Mu X.J., BruceKeller A.J., Mattson M.P., and Springer J.E. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 765 (1997) 283-290
6. Bastianetto S., and Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23 (2002) 891-897
7. Bates J.N., Baker M.T., Guerra R., and Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Biochem. Pharmacol. 42 (1991) 157-165
8. Behan W.M., McDonald M., Darlington L.G., and Stone T.W. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br. J. Pharmacol. 128 (1999) 1754-1760
9. Bellé N.A.V., Dalmolin G.D., Fonini G., Rubin M.A., and Rocha J.B.T. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res. 1008 (2004) 245-251
10. Bixby M., Spieler L., Menini T., and Gugliucci A. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci. 77 (2005) 345-358
11. Bolanos J., and Almeida A. Roles of nitric oxide in brain hypoxia-ischemia. Biochim. Biophys. Acta 1411 (1999) 415-436
12. Bors W., and Michel C. Antioxidant capacity of flavanols and gallate esters: pulse radiolysis studies. Free Radical Biol. Med. 27 (1999) 1413-1426
13. Bors W., Michel C., and Stettmaier K. Structure-activity relationships governing antioxidant capacities of plant polyphenols. Methods Enzymol. 335 (2001) 166-180
14. Burger M.E., Fachinetto R., Calegari L., Paixão M.W., Braga A.L., and Rocha J.B.T. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Brain Res. Bull. 64 (2004) 339-345
15. Burger M.E., Fachineto R., Alves A., Callegari L., and Rocha J.B.T. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res. 1031 (2005) 202-210
16. Cabrera J., Reiter R.J., Tan D., Qi W., Sainz R.M., Mayo J.C., Garcia J.J., Kim S.J., and El-Sokkary G. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology 39 (2000) 507-514
17. Camuesco D., Comalada M., Rodriguez-Cabezas M.E., Nieto A., Lorente M.D., Concha A., Zarzuelo A., and Galvez J. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 143 (2004) 908-918
18. Castill J., Rama R., and Davalos A. Nitric oxide-related brain damage in acute ischemic stroke. Stroke 31 (2000) 852-857
19. Chen J., Chang B., Williams M., and Murad F. Sodium nitroprusside degenerates cultured rat striatal neurons. NeuroReport 2 (1991) 121-123
20. Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Galvez J., and Zarzuelo A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappa B pathway. Eur. J. Immunol. 35 (2005) 584-592
21. Cooke D., Steward W.P., Gescher A.J., and Marczylo T. Anthocyans from fruits and vegetables-Does bright colour signal cancer chemopreventive activity?. Eur. J. Cancer 41 (2005) 1931-1940
22. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6368-6371
23. Dominguez M., Nieto A., Marin J.C., Keck A.S., Jeffery E., and Cespedes C.L. Antioxidant activities of extracts from Barkleyanthus salicifolius (Asteraceae) and Penstemon gentianoides (Scrophularlaceae). J. Agric. Food Chem. 53 (2005) 5889-5895
24. Filip R., Lopez P., Giberti G., Coussio J., and Ferraro G. Phenolic compounds in seven South American Ilex species. Fitoterapia 72 (2001) 774-778
25. Foster A.C., Collins J.F., and Schwarcz R. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 22 (1983) 1331-1342
26. Gee J.M., Dupont M.S., Rhodes M.J.C., and Johnson I.T. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radical Biol. Med. 25 (1998) 19-25
27. Ghisleine G., Porciúncula L.O., Cimarosti H., Rocha J.B.T., Salbego C.G., and Souza D.O. Diphenyl diselenide protects rat hippocampal slices submited to oxygen-glucose deprivation and diminishes inducible nitric oxide synthase immunocontent. Brain Res. 986 (2003) 196-199
28. Graf E., Mahoney J.R., Bryant R.G., and Eaton J.W. Iron catalyzed hydroxyl radical formation: stringent requirement for free iron coordination site. J. Biol. Chem. 259 (1984) 3620-3624
29. Goda K., Kishimoto R., Shimizu S., Hamane Y., and Ueda M. Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain. Adv. Exp. Med. Biol. 398 (1996) 247-254
30. Gugliucci A., and Stahl A.J. Low density lipoprotein oxidation is inhibited by extracts of Ilex paraguariensis. Biochem. Mol. Biol. Int. 35 (1995) 47-56
31. Gupta R., Singh M., and Sharma A. Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacol. Res. 48 (2003) 209-215
32. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence?. Lancet 344 (1994) 721-724
33. Halliwell B., Gutteridge J.M.C., and Aruoma O.I. The deoxyribose method: a simple "Test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem. 165 (1987) 215-219
34. Hollman P.C., and Katan M.B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 51 (1997) 305-310
35. Hollman P.C.H., and Katan M.B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37 (1999) 937-942
36. Hollman P.C.H., Devries J.H.M., Vanleeuwen S.D., Mengelers M.J.B., and Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62 (1995) 1276
37. Iwahashi H., Kawamori H., and Fukushima K. Quinolinic acid, alpha-picolinic acid, fusaric acid, and 2,6-pyridinedicarboxylic acid enhance the Fenton reaction in phosphate buffer. Chem.-Biol. Interact. 118 (1999) 201-215
38. Johnson I.T. New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat. Res., Fundam. Mol. Mech. Mutagen. 551 (2004) 9-28
39. Jovanovic S.V., Steenken S., Simic M.G., and Hara Y. Antioxidant properties of flavonoids: reduction potentials and electron transfer reactions of flavonoid radicals. In: Rice-Evans C., and Packer L. (Eds). Flavonoids in Health and Disease (1998), Macel Dekker, New York 137
40. Justino G.C., Santos M.R., Canário S., Borges C., Florêncio M.H., and Mira L. Plasma quercetin metabolites: structure-antioxidant activity relationships. Arch. Biochem. Biophys. 432 (2004) 109-121
41. Lohr J.B. Oxygen radicals and neuropsychiatric illness-Some speculations. Arch. Gen. Psychiatry 48 (1991) 1097-1106
42. Loiacono R.E., and Beart P.M. Hippocampal-lesions induced by microinjection of the nitric-oxide donor nitroprusside. Eur. J. Phamacol. 216 (1992) 331-333
43. Lois G., Puía G., Garzon G., de Vuono M.C., and Baraldi M. Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons. Eur. J. Pharmacol. 502 (2004) 41-46
44. Morand C., Manach C., Crespy V., and Rémésy C. Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radic. Res. 33 (2000) 667
45. Moridani M.Y., Pourahmad J., Bui H., Siraki A., and O'Brien J. Dietary flavonoids iron complexes as cytoprotective superoxide radical scavengers. Free Radical Biol. Med. 34 (2003) 243-253
46. Naidu P.S., Singh A., and Kulkarni S.K. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 44 (2003) 1100-1106
47. Nogueira C.W., Zeni G., and Rocha J.B.T. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem. Rev. 104 (2004) 6255-6285
48. Ohkawa H., Ohishi H., and Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
49. Park J.Y., Kim E.J., Kwon K.J., Jung Y.S., Moon C.H., Lee S.H., and Baik E.J. Neuroprotection by fructose-1,6-bisphosphate involves ROS alterations via p38 MAPK/ERK. Brain Res. 1026 (2004) 295-301
50. Perez-de la Cruz V., Gonzalez-Cortes C., Galvan-Arzate S., Medina-Campos O.N., Perez-Severiano F., Ali S.F., Pedraza-Chaverri J., and Santamaria A. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl) porphyrinate iron (III). Neuroscience 135 (2005) 463-474
51. Pérez-Severiano P., Rodríguez-Pérez M., Pedraza-Chaverrí J., Maldonado P.D., Medina-Campos O.N., Ortíz-Plata A., Sánchez-García A., Villeda-Hernández J., Galván-Arzate S., Aguilera P., and Santamaría A. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem. Int. 45 (2004) 1175-1183
52. Prast H., and Philippou A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
53. Puntel R.L., Nogueira C.W., and Rocha J.B.T. N-methyl-d-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in vitro. Neurochem. Res. 30 (2005) 417-424
54. Rauhala P., KhaldiI A., Mohanakumar K.P., and Chiueh C.C. Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radical Biol. Med. 24 (1998) 1065-1073
55. Rice-Evans C., and Burdon R. Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res. 32 (1993) 71-110
56. Rice-Evans C.A., Miller N.J., and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol. Med. 20 (1996) 933-956
57. Ríos C., and Santamaría A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 16 (1991) 1139-1143
58. Rossato J.I., Zeni G., Mello C.F., Rubin M.A., and Rocha J.B.T. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci. Let. 318 (2002) 137-140
59. Rodriguez-Martinez E., Camacho A., Maldonado P.D., Pedraza-Chaverri J., Santamaria D., Galvan-Arzate S., and Santamaria A. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res. 858 (2000) 436-439
60. Santamaria A., Jimenez-Capdeville M.E., Camacho A., Rodriguez-Martinez E., Flores A., and Galvan-Arzate S. In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. Neuroreport 12 (2001) 2693-2696
61. Santamaría A., Salvatierra-Sanchez R., Vazquez-Roman B., Santiago-Lopez D., Villeda-Hernandez J., Galvan-Arzates S., Jimenez-Capdeville M.E., and Ali S.F. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J. Neurochem. 86 (2003) 479-488
62. Scalbert T.W. Neuropharmacology of quinolinic an kynurenic acids. Pharmacol. Rev. 45 (1993) 309-379
63. Scalbert A., Morand C., Manach C., and Rémésy C. Absorption and metabolism of polyphenols in the gut and impact of health. Biomed. Pharmacother. 56 (2002) 276-282
64. Singh R.J., Hogg N., Neese F., Joseph J., and Kalyanaraman B. Trapping of nitric oxide formed during photolysis of sodium nitroprusside in aqueous and lipid phases: an electron spin resonance study. Photochem. Photobiol. 61 (1995) 325-330
65. Stipek S., Stastany F., Platenik J., Crkovska J., and Zima T. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem. Int. 30 (1997) 233-237
66. Steffen Y., Schewe T., and Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem. Biophys. Res. Com. 331 (2005) 1277-1283
67. Stýpek S., Stastny F., Platenýk J., Crkovska J., and Zima T. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem. Int. 30 (1997) 233-237
68. Susel Z., Engber T.M., and Chase T.N. Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements. Neurosci. Lett. 104 (1989) 125-129
69. Vega-Naredo I., Poeggeler B., Sierra-Sanchez V., Caballero B., Tomas-Zapico C., Alvarez-Garcia O., Tolivia D., Rodriguez-Colunga M.J., and Coto-Montes A. Melatonin neutralizes neurotoxicity induced by quinolinic acid in brain tissue culture. J. Pineal. Res. 39 (2005) 266-275
70. Xu X., Zhang S., Zhang L., Yan W., and Zheng X. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 71 (2005) 585-591
71. Weisinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog. Neurobiol. 64 (2001) 365-391
72. Williams R.J., Spencer J.P.E., and Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radical Biol. Med. 36 (2004) 838-849
73. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
74. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., and Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radical Biol. Med. 36 (2004) 592-604